Beyond Air XAIR
NASDAQ XAIR
$5.17 -0.04 (-0.77%)
At close: Aug 20, 2026 · 2:12 PM UTC

Beyond Air (XAIR) Acquisitions (2017)

Beyond Air (XAIR) posted Acquisitions of -$138.0 for Q4 2017, down 200.0% sequentially from $138.0 in Q2 2017.

Beyond Air (XAIR) Acquisitions (2017) Analysis & Trends

Beyond Air has reported Acquisitions for 1 years, with the latest figure at -$138.0 in Q4 2017.

  • Quarterly Acquisitions changed N/A year-over-year to -$138.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $294862.0 (changed N/A YoY) and the FY2019 annual result came in at $20.0 million, changed N/A from the prior year.
  • Acquisitions declined to -$138.0 in Q4 2017 per XAIR's latest filing, from $138.0 in the prior quarter.
  • Over five years, Acquisitions peaked at $294862.0 in Q1 2017 and troughed at -$138.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn -
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 437.00 Mn
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn -
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn -
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn -4.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -3.49 Mn
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 16.00 Mn
10 Beyond Air 3.73 Mn -7.18 Mn 225,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2017 -138.00
Jun 30, 2017 138.00
Mar 31, 2017 294,862.00